SCHEMBL7091163

SCHEMBL7091163

NC(=O)c1ccc(-c2nn(Cc3ccccc3)c3ccsc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 1/20 0.47
ERCC5 P28715 2/20 0.46
CYP2D6 P10635 1/20 0.44
RORC P51449 2/20 0.42
FYN P06241 1/20 0.42
GRK5 P34947 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
ADORA1 P30542 1/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
PLA2G10 O15496 1/20 0.40
PLA2G2A P14555 1/20 0.40
FEN1 P39748 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KCNK3 O14649 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 1/20 0.39
ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094721 0.85 ADORA1 (0.50) F2RL3ERCC5CYP2D6ADORA3ADORA1
SCHEMBL7096390 0.84 BTK (0.42) F2RL3ERCC5CYP2D6ADORA3ADORA1
SCHEMBL7094701 0.84 ESR1 (0.53) F2RL3ERCC5CYP2D6ADORA3ADORA1
SCHEMBL7090320 0.82 ALDH1A1 (0.54) F2RL3ERCC5CYP2D6ADORA3ADORA1
SCHEMBL6994778 0.81 ADORA1 (0.45) F2RL3ERCC5CYP2D6ADORA3ADORA1
SCHEMBL7500320 0.74 PDE5A (0.46) ERCC5CYP2D6CYP2C9CYP2C19FEN1
SCHEMBL7093526 0.74 KMT2A (0.50) CYP2D6ADORA1CYP2C9CYP2C19ALDH1A1
SCHEMBL2950333 0.71 PDE5A (0.46) F2RL3CYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL4485942 0.70 RORC (0.76) F2RL3CYP2D6RORCCYP2C9CYP2C19
SCHEMBL2953485 0.70 PDE5A (0.67) ERCC5CYP2D6CYP2C9CYP2C19FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed